Forbion raises in excess of €2bn for two new funds
Forbion, a global life sciences venture capital firm focused on Europe, has raised over €2bn ($2.2bn) across its two newest funds, Forbion Growth Opportunities III and Forbion Ventures VII, bringing total assets under management to €5bn ($5.5bn).

